Ziegler Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$7.85M Buy
82,173
+3,668
+5% +$308K 0.3% 110
2023
Q4
$5.99M Sell
78,505
-6,075
-7% -$423K 0.27% 87
2023
Q3
$5.86M Sell
84,580
-3,350
-4% -$269K 0.23% 150
2023
Q2
$8.29M Sell
87,930
-1,419
-2% -$123K 0.32% 118
2023
Q1
$7.39M Buy
89,349
+2,365
+3% +$186K 0.29% 130
2022
Q4
$6.49M Sell
86,984
-5,895
-6% -$454K 0.27% 135
2022
Q3
$7.67M Sell
92,879
-27,033
-23% -$2.6M 0.34% 104
2022
Q2
$11.4M Buy
119,912
+72,052
+151% +$7.46M 0.47% 63
2022
Q1
$5.64M Buy
47,860
+3,103
+7% +$348K 0.24% 146
2021
Q4
$5.8M Sell
44,757
-2,494
-5% -$291K 0.21% 163
2021
Q3
$5.34M Buy
47,251
+39,516
+511% +$4.51M 0.19% 174
2021
Q2
$6.75M Sell
7,735
-56,910
-88% -$5.36M 0.23% 161
2021
Q1
$5.41M Buy
64,645
+552
+0.9% +$46.7K 0.17% 192
2020
Q4
$5.85M Sell
64,093
-1,615
-2% -$134K 0.19% 178
2020
Q3
$5.24M Sell
65,708
-225,849
-77% -$17.6M 0.2% 179
2020
Q2
$20.2M Sell
291,557
-46,828
-14% -$3.33M 0.64% 33
2020
Q1
$25.8M Buy
+338,385
New +$24.4M 0.69% 28

Other funds holding EW

Ziegler Capital Management's EW Position: Q1 2024 in Review

Ziegler Capital Management increased its Edwards Lifesciences (EW) stake by 4.7% in Q1 2024, buying an estimated $308K and bringing the position to 82,173 shares worth $7.85M. The position accounts for 0.3% of the portfolio, ranked #110.

Ziegler Capital Management first reported a position in EW in Q1 2020 and has held it in 17 quarters since. The position peaked at $25.8M in Q1 2020. 1,280 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • Ziegler Capital Management held 82,173 shares of Edwards Lifesciences worth $7.85M as of Q1 2024.
  • Ziegler Capital Management bought 3,668 Edwards Lifesciences shares in Q1 2024, an estimated $308K.
  • Edwards Lifesciences made up 0.3% of Ziegler Capital Management's portfolio in Q1 2024, its #110 holding.
  • Ziegler Capital Management first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 17 quarters since.
  • Ziegler Capital Management's Edwards Lifesciences position peaked at $25.8M in Q1 2020.
  • 1,280 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.